H-1B sponsorship profile: Teva Branded Pharmaceutical Products R&D, Inc. Across U.S. Department of Labor LCA disclosures, Teva Branded Pharmaceutical Products R&D, Inc filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Teva Branded Pharmaceutical Products R&D, Inc’s H-1B petitions range from $111,600 at the low end to $255,000 at the high end, with a petition-weighted average of $159,014. That range reflects the mix of occupations the company sponsors, led by Sr. Manager – Global Data, Analytics & Reporting (2 petitions at $134,000 avg), followed by Senior Director Research & Development, Analytical Sciences and Scientist, Analytical Chemistry. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Teva Branded Pharmaceutical Products R&D, Inc is headquartered in Parsippany, NJ under NAICS code 325412, and places H-1B workers across 2 states, most heavily in PA, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Teva Branded Pharmaceutical Products R&D, Inc ranks. By H-1B petition volume, Teva Branded Pharmaceutical Products R&D, Inc is #21,197 of 119,880 employers nationally and #1,653 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.